CHSCP CHS Forecast, Technical & Fundamental Analysis

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CHSCP as a result. In 21 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 20%.

The Moving Average Convergence Divergence Histogram (MACD) for CHSCP turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 54 similar instances when the indicator turned negative. In 10 of the 54 cases the stock turned lower in the days that followed. This puts the odds of success at 19%.

The 10-day moving average for CHSCP crossed bearishly below the 50-day moving average on September 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 19%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHSCP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 20%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for CHSCP's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.23% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHSCP advanced for three days, in 58 of 320 cases, the price rose further within the following month. The odds of a continued upward trend are 18%.

CHSCP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (2.673). P/E Ratio (0.000) is within average values for comparable stocks, (33.850). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.441). CHSCP has a moderately high Dividend Yield (0.077) as compared to the industry average of (0.034). P/S Ratio (0.000) is also within normal values, averaging (2.353).

The Tickeron Price Growth Rating for this company is 68 (best 1 - 100 worst), indicating slightly worse than average price growth. CHSCP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHSCP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.